Amersham ECL Prime Chemiluminescent Western Blotting Reagent

Highly sensitive, stable detection of small protein quantities GE Healthcare has introduced Amersham™ ECL™ Prime, a highly sensitive reagent characterised by stable signal emission up to 3 hours after addition of the reagent, allowing for the possibility of repeated exposures and making it easier to process several blots in the same experimental run. High signal intensity means that proteins may be detected using more dilute primary and secondary antibodies, which reduces background noise and reagent consumption.

Amersham ECL Prime is optimised for CCD based imaging with ImageQuant™ LAS 4000, and is compatible with Amersham Hyperfilm™. The reagent is optimised for use with Amersham Hybond™-P (PVDF) membranes and compatible with Amersham Hybond-ECL (nitrocellulose) membranes and for any other standard films and membranes..

GE Healthcare’s enhanced chemiluminescence (ECL) Western Blotting System portfolio provides tools for  applications ranging from routine protein detection to multiplex analysis using fluorescence-based Amersham ECL Plex™. It is a workflow solution for faster, more sensitive and more flexible protein analysis.